文献速递糖尿病肥胖与代谢综合征

细胞外液容量扩张揭示GLP-1的促钠尿作用:人体功能性GLP-1-肾脏轴

Extracellular Fluid Volume Expansion Uncovers a Natriuretic Action of GLP-1: A Functional GLP-1-Renal Axis in Man.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

在固定钠摄入下,8名健康男性随机接受3小时GLP-1(1.5 pmol/kg/min)或溶剂输注,同时静脉输注0.9% NaCl扩容。GLP-1输注期间尿钠和渗透压排泄显著增加,血浆肾素两组均降低,血管紧张素II仅在GLP-1输注时显著降低,而肾血浆流量和肾小球滤过率均不变。结论:容量扩张状态下GLP-1通过抑制血管紧张素II的肾小管机制促进钠尿,不依赖肾脏血流动力学,支持GLP-1-肾脏轴的存在。

要点

  • 容量扩张状态下GLP-1输注可显著增加尿钠和渗透压排泄。
  • GLP-1的促钠尿作用不依赖肾血浆流量和肾小球滤过率的变化。
  • 血管紧张素II仅在GLP-1输注时显著降低,提示肾小管机制介导。

核心结论

  • 在容量扩张的健康男性中,GLP-1通过抑制血管紧张素II的肾小管机制促进钠尿,不依赖肾脏血流动力学,支持GLP-1-肾脏轴的存在。

研究设计与样本

  • 研究纳入8名健康男性,在固定钠摄入下随机顺序接受3小时GLP-1(1.5 pmol/kg/min)或溶剂输注,同时静脉输注0.9% NaCl,进行定时尿收集,采用Fick原理测量肾血浆流量、肾小球滤过率及激素和离子的摄取与释放。

主要发现

  • GLP-1输注期间尿钠和渗透压排泄较溶剂输注显著增加。
  • 血浆肾素水平在两组均相似降低,而血管紧张素II水平仅在GLP-1输注时显著降低。
  • 肾血浆流量和肾小球滤过率在两组均保持不变。

临床怎么用

  • 提示GLP-1相关药物在容量扩张状态下可能具有促钠尿作用,临床需关注其对钠平衡和血压的潜在影响。

局限性

  • 研究仅纳入8名健康男性,样本量小,结果外推需谨慎。
  • 研究为短期输注实验,长期临床效应未明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We have previously demonstrated that glucagon-like peptide-1 (GLP-1) does not affect renal hemodynamics or function under baseline conditions in healthy participants and in patients with type 2 diabetes mellitus. However, it is possible that GLP-1 promotes natriuresis under conditions with addition of salt and water to the extracellular fluid. The current study was designed to investigate a possible GLP-1-renal axis, inducing natriuresis in healthy, volume-loaded participants. METHODS: Under fixed sodium intake, eight healthy men were examined twice in random order during a 3-hour infusion of either GLP-1 (1.5 pmol/kg/min) or vehicle together with an intravenous infusion of 0.9% NaCl. Timed urine collections were conducted throughout the experiments. Renal plasma flow (RPF), glomerular filtration rate (GFR), and uptake and release of hormones and ions were measured via Fick's principle. RESULTS: During GLP-1 infusion, urinary sodium and osmolar excretions increased significantly compared with vehicle. Plasma renin levels decreased similarly on both days, whereas angiotensin II (ANG II) levels decreased significantly only during GLP-1 infusion. RPF and GFR remained unchanged on both days. CONCLUSIONS: In volume-loaded participants, GLP-1 induces natriuresis, probably brought about via a tubular mechanism secondary to suppression of ANG II, independent of renal hemodynamics, supporting the existence of a GLP-1-renal axis.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Asmar A, Cramon PK, Simonsen L, et al. Extracellular Fluid Volume Expansion Uncovers a Natriuretic Action of GLP-1: A Functional GLP-1-Renal Axis in Man. J Clin Endocrinol Metab. 2019. PMID: 30835273. doi:10.1210/jc.2019-00004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。